Five renowned cardiothoracic surgeons discuss how percutaneous mitral valve repair technology fits into the playbook for treatment of patients with mitral regurgitation. They talk about indications, complications, adoption rates, and new FDA rules that have accelerated use of this exciting new technology in select patients in the US.
Vinod H. Thourani, MD – Emory University, Atlanta (@emoryhealthcare)
Michael J. Mack, MD – Baylor Scott & White Healthcare, Dallas (@BaylorHealth)
Wilson Y. Szeto, MD – University of Pennsylvania, Philadelphia (@Penn)
Eric E. Roselli, MD – Cleveland Clinic (@ClevelandClinic)
Gorav Ailawadi, MD – University of Virginia, Charlottesville (@UVAhealthnews)